Tandem Diabetes Care (TNDM) Other Non-Current Assets (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Non-Current Assets came in at $30.8 million in Q1 2026, up 312.89% YoY from $7.5 million in Q1 2025, and up 34.78% on a QoQ basis from $22.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Other Non-Current Assets data on file, last reported at $30.8 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 312.89% year-over-year to $30.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.8 million (up 312.89% YoY) and the FY2025 annual result came in at $22.9 million, up 342.62% from the prior year.
- Other Non-Current Assets advanced to $30.8 million in Q1 2026, from $22.9 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $40.3 million in Q4 2023 to a low of $5.2 million in Q4 2024.
- A 5-year average of $22.6 million and a median of $17.6 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 87.19% — and 2025, when it soared 342.62%.
- Tracing TNDM's Other Non-Current Assets over 5 years: stood at $23.6 million in 2022, then jumped by 70.69% to $40.3 million in 2023, then sank by 87.19% to $5.2 million in 2024, then soared by 342.62% to $22.9 million in 2025, then surged by 34.78% to $30.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $30.8 million (Q1 2026), $22.9 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 32.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.61 Mn |
| Mar 31, 2026 | 30.82 Mn |
| Dec 31, 2025 | 22.87 Mn |
| Sep 30, 2025 | 16.52 Mn |
| Jun 30, 2025 | 17.34 Mn |
| Mar 31, 2025 | 7.46 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 36.45 Mn |
| Jun 30, 2024 | 37.25 Mn |
| Mar 31, 2024 | 40.04 Mn |
| Dec 31, 2023 | 40.34 Mn |
| Sep 30, 2023 | 16.57 Mn |
| Jun 30, 2023 | 17.57 Mn |
| Mar 31, 2023 | 16.91 Mn |
| Dec 31, 2022 | 23.63 Mn |
| Sep 30, 2022 | 23.84 Mn |
| Jun 30, 2022 | 15.96 Mn |
| Mar 31, 2022 | 15.77 Mn |
| Dec 31, 2021 | 15.73 Mn |
| Sep 30, 2021 | 16.03 Mn |